• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4630713)   Today's Articles (3065)   Subscriber (49841)
For: Marx N, Floege J. Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial. Eur Heart J 2021;42:1228-1230. [PMID: 33792668 PMCID: PMC8014504 DOI: 10.1093/eurheartj/ehab092] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]  Open
Number Cited by Other Article(s)
1
Crea F. Sodium-glucose cotransporter 2 inhibitors, weight loss therapies, and ferric carboxymaltose: new light shed on innovative ways to reduce cardiovascular risk. Eur Heart J 2023;44:5009-5014. [PMID: 38124671 DOI: 10.1093/eurheartj/ehad815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]  Open
2
Crea F. Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction. Eur Heart J 2023;44:4203-4207. [PMID: 37864782 DOI: 10.1093/eurheartj/ehad706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2023]  Open
3
Crea F. Focus on heart failure and cardiomyopathies: new ESC Guidelines and key meta-analyses. Eur Heart J 2023;44:3487-3491. [PMID: 37778030 DOI: 10.1093/eurheartj/ehad647] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/03/2023]  Open
4
Crea F. Late breaking trials in heart failure. Eur Heart J 2023;44:2877-2882. [PMID: 37579050 DOI: 10.1093/eurheartj/ehad516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 08/16/2023]  Open
5
Crea F. Challenges and opportunities in the management of acute heart failure and cardiac amyloidosis. Eur Heart J 2023;44:2135-2139. [PMID: 37356037 DOI: 10.1093/eurheartj/ehad403] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/27/2023]  Open
6
Crea F. Epidemiology and treatment of acute and chronic heart failure. Eur Heart J 2023;44:329-332. [PMID: 36722157 DOI: 10.1093/eurheartj/ehad022] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]  Open
7
Crea F. Acute and chronic heart failure: exciting therapeutic perspectives. Eur Heart J 2023;44:1-4. [PMID: 36586417 DOI: 10.1093/eurheartj/ehac767] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]  Open
8
Crea F. Focus on trials: dementia, lipids, thrombosis, and heart failure. Eur Heart J 2022;43:4965-4969. [PMID: 36542413 DOI: 10.1093/eurheartj/ehac746] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]  Open
9
Crea F. Cardiomyopathies and myocardial fibrosis: diagnostic and therapeutic challenges. Eur Heart J 2022;43:4665-4668. [PMID: 36450341 DOI: 10.1093/eurheartj/ehac688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/05/2022]  Open
10
Crea F. Sodium–glucose co-transporter 2 inhibition: the saga continues. Eur Heart J 2022;43:4215-4218. [DOI: 10.1093/eurheartj/ehac590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
11
Crea F. Pulmonary hypertension, sarcoidosis, and inflammatory and dilated cardiomyopathy: new light shed on prevalence, mechanisms, and treatment. Eur Heart J 2022;43:3371-3375. [PMID: 36130231 DOI: 10.1093/eurheartj/ehac497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]  Open
12
Crea F. Lipid lowering beyond statins and methodological issues in cardiovascular clinical trials. Eur Heart J 2022;43:1365-1368. [PMID: 35388411 DOI: 10.1093/eurheartj/ehac158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
13
Crea F. Dyslipidaemias in stroke, chronic kidney disease, and aortic stenosis: the new frontiers for cholesterol lowering. Eur Heart J 2021;42:2137-2140. [PMID: 34097728 DOI: 10.1093/eurheartj/ehab295] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
14
Crea F. Challenges in heart failure: quality of life, chronic kidney disease, and secondary mitral regurgitation. Eur Heart J 2021;42:1185-1189. [PMID: 33792670 DOI: 10.1093/eurheartj/ehab154] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA